Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-05-02 | Aerovate Therapeutics, Inc. | Verwijs Marinus
(CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 1981 | $21.02 - $21.02 | $41,630 |
| 2024-05-01 | Aerovate Therapeutics, Inc. | NOYES TIMOTHY P
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 11357 | $19.91 - $20.87 | $230,944 |
| 2024-05-01 | Aerovate Therapeutics, Inc. | NOYES TIMOTHY P
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 10000 | $2.14 - $2.14 | $21,400 |
| 2024-04-17 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
S | Common Stock | D | 6853 | $22.32 - $23.97 | $153,325 |
| 2024-04-17 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
M | Common Stock | A | 6853 | $2.14 - $2.14 | $14,665 |
| 2024-04-17 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 4000 | $22.30 - $23.33 | $89,520 |
| 2024-04-17 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 4000 | $1.74 - $1.74 | $6,960 |
| 2024-04-16 | Aerovate Therapeutics, Inc. | NOYES TIMOTHY P
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 10000 | $24.40 - $24.94 | $246,969 |
| 2024-04-16 | Aerovate Therapeutics, Inc. | NOYES TIMOTHY P
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 10000 | $2.14 - $2.14 | $21,400 |
| 2024-04-10 | Aerovate Therapeutics, Inc. | Eldridge George A
(SEE REMARKS) |
S | Common Stock | D | 7500 | $26.77 - $27.56 | $201,391 |
| 2024-04-10 | Aerovate Therapeutics, Inc. | Eldridge George A
(SEE REMARKS) |
M | Common Stock | A | 7500 | $2.14 - $2.14 | $16,050 |
| 2024-04-09 | Aerovate Therapeutics, Inc. | GRAYZEL DAVID S.
(Director) |
S | Common Stock | D | 11882 | $28.15 - $28.15 | $334,478 |
| 2024-04-01 | Aerovate Therapeutics, Inc. | NOYES TIMOTHY P
(CHIEF EXECUTIVE OFFICER) |
S | Common Stock | D | 10000 | $28.96 - $31.95 | $300,032 |
| 2024-04-01 | Aerovate Therapeutics, Inc. | NOYES TIMOTHY P
(CHIEF EXECUTIVE OFFICER) |
M | Common Stock | A | 10000 | $2.14 - $2.14 | $21,400 |
| 2024-04-01 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
S | Common Stock | D | 3325 | $31.97 - $31.97 | $106,316 |
| 2024-04-01 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
M | Common Stock | A | 3325 | $10.61 - $10.61 | $35,278 |
| 2024-03-28 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 9000 | $29.50 - $29.50 | $265,500 |
| 2024-03-28 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 9000 | $2.14 - $2.14 | $19,260 |
| 2024-03-27 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
S | Common Stock | D | 11068 | $27.97 - $27.97 | $309,518 |
| 2024-03-27 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
M | Common Stock | A | 11068 | $10.61 - $10.61 | $117,431 |
| 2024-03-25 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
S | Common Stock | D | 3432 | $28.01 - $28.01 | $96,119 |
| 2024-03-25 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
M | Common Stock | A | 3432 | $10.61 - $10.61 | $36,413 |
| 2024-03-19 | Aerovate Therapeutics, Inc. | Verwijs Marinus
(CHIEF TECHNICAL OFFICER) |
S | Common Stock | D | 5300 | $25.68 - $26.46 | $138,242 |
| 2024-03-19 | Aerovate Therapeutics, Inc. | Verwijs Marinus
(CHIEF TECHNICAL OFFICER) |
M | Common Stock | A | 5300 | $14.59 - $14.59 | $77,327 |
| 2024-03-18 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 7000 | $25.81 - $26.40 | $181,056 |
| 2024-03-18 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 7000 | $1.74 - $2.14 | $13,380 |
| 2024-03-18 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
S | Common Stock | D | 35057 | $25.74 - $26.48 | $908,044 |
| 2024-03-18 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
M | Common Stock | A | 35057 | $2.14 - $10.61 | $197,836 |
| 2024-03-12 | Aerovate Therapeutics, Inc. | Eldridge George A
(SEE REMARKS) |
S | Common Stock | D | 4067 | $25.02 - $25.05 | $101,813 |
| 2024-03-12 | Aerovate Therapeutics, Inc. | Eldridge George A
(SEE REMARKS) |
M | Common Stock | A | 4067 | $2.14 - $2.14 | $8,703 |
| 2024-03-07 | Aerovate Therapeutics, Inc. | Eldridge George A
(SEE REMARKS) |
S | Common Stock | D | 25933 | $25.00 - $26.30 | $649,205 |
| 2024-03-07 | Aerovate Therapeutics, Inc. | Eldridge George A
(SEE REMARKS) |
M | Common Stock | A | 25933 | $2.14 - $2.14 | $55,495 |
| 2024-03-07 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 8975 | $24.50 - $24.50 | $219,887 |
| 2024-03-07 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 8975 | $2.14 - $2.14 | $19,206 |
| 2024-02-23 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 511 | $19.50 - $19.50 | $9,964 |
| 2024-02-23 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 511 | $1.74 - $1.74 | $889 |
| 2024-02-20 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 3489 | $20.11 - $20.58 | $70,573 |
| 2024-02-20 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 3489 | $1.74 - $1.74 | $6,070 |
| 2024-02-05 | Aerovate Therapeutics, Inc. | NIVEN RALPH
(CHIEF SCIENTIFIC OFFICER) |
S | Common Stock | D | 4600 | $17.45 - $17.45 | $80,249 |
| 2024-02-05 | Aerovate Therapeutics, Inc. | NIVEN RALPH
(CHIEF SCIENTIFIC OFFICER) |
M | Common Stock | A | 4600 | $1.74 - $2.14 | $9,284 |
| 2024-01-05 | Aerovate Therapeutics, Inc. | NIVEN RALPH
(CHIEF SCIENTIFIC OFFICER) |
S | Common Stock | D | 4600 | $18.67 - $19.57 | $88,115 |
| 2024-01-05 | Aerovate Therapeutics, Inc. | NIVEN RALPH
(CHIEF SCIENTIFIC OFFICER) |
M | Common Stock | A | 4600 | $1.74 - $2.14 | $9,284 |
| 2023-12-13 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
S | Common Stock | D | 12000 | $19.50 - $19.50 | $233,999 |
| 2023-12-13 | Aerovate Therapeutics, Inc. | Gillies Hunter
(CHIEF MEDICAL OFFICER) |
M | Common Stock | A | 12000 | $1.74 - $1.74 | $20,879 |
| 2023-12-06 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
S | Common Stock | D | 10283 | $16.11 - $16.11 | $165,628 |
| 2023-12-06 | Aerovate Therapeutics, Inc. | Dake Benjamin T
(SEE REMARKS) |
M | Common Stock | A | 10283 | $1.74 - $2.14 | $21,041 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |